insights_auto
Why is MBIO down 8,63%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
0,38 $
arrow_downward
-8,63%(-0,036) 1D
0,37 $
arrow_downward
-1,01% (-0,0038)todayPre-market
Closed: 13 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
0,39 $
High
0,40 $
Low
0,37 $
Mkt. cap
2,87 մլն
Avg. vol.
32,47 հզր
Volume
4,11 հզր
52-wk high
1,69 $
52-wk low
0,37 $
EPS
-0,46 $
Beta
2,09
Shares outstanding
6,73 մլն
No. of employees
4
Open
0,39 $
High
0,40 $
Low
0,37 $
Mkt. cap
2,87 մլն
Avg. vol.
32,47 հզր
Volume
4,11 հզր
52-wk high
1,69 $
52-wk low
0,37 $
EPS
-0,46 $
Beta
2,09
Shares outstanding
6,73 մլն
No. of employees
4
News stories
From web sources and news partners
ad-hoc-news.de
·
10 ժամ առաջ
Mustang Bio stock sits 2.70 percent above its yearly low
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitemustangbio.com